Yüklüyor......
Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery
This study evaluated the safety and tolerability of ocular RS1 adeno-associated virus (AAV8-RS1) gene augmentation therapy to the retina of participants with X-linked retinoschisis (XLRS). XLRS is a monogenic trait affecting only males, caused by mutations in the RS1 gene. Retinoschisin protein is s...
Kaydedildi:
| Yayımlandı: | Mol Ther |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Gene & Cell Therapy
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6127971/ https://ncbi.nlm.nih.gov/pubmed/30196853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.05.025 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|